Literature DB >> 26687685

HIV-1 gp140 epitope recognition is influenced by immunoglobulin DH gene segment sequence.

Yuge Wang1, Pratibha Kapoor2, Robert Parks3, Aaron Silva-Sanchez1,4, S Munir Alam3, Laurent Verkoczy3, Hua-Xin Liao3, Yingxin Zhuang4, Peter Burrows1, Michael Levinson1, Ada Elgavish4, Xiangqin Cui2, Barton F Haynes3, Harry Schroeder5,6.   

Abstract

Complementarity Determining Region 3 of the immunoglobulin (Ig) H chain (CDR-H3) lies at the center of the antigen-binding site where it often plays a decisive role in antigen recognition and binding. Amino acids encoded by the diversity (DH) gene segment are the main component of CDR-H3. Each DH has the potential to rearrange into one of six DH reading frames (RFs), each of which exhibits a characteristic amino acid hydrophobicity signature that has been conserved among jawed vertebrates by natural selection. A preference for use of RF1 promotes the incorporation of tyrosine into CDR-H3 while suppressing the inclusion of hydrophobic or charged amino acids. To test the hypothesis that these evolutionary constraints on DH sequence influence epitope recognition, we used mice with a single DH that has been altered to preferentially use RF2 or inverted RF1. B cells in these mice produce a CDR-H3 repertoire that is enriched for valine or arginine in place of tyrosine. We serially immunized this panel of mice with gp140 from HIV-1 JR-FL isolate and then used enzyme-linked immunosorbent assay (ELISA) or peptide microarray to assess antibody binding to key or overlapping HIV-1 envelope epitopes. By ELISA, serum reactivity to key epitopes varied by DH sequence. By microarray, sera with Ig CDR-H3s enriched for arginine bound to linear peptides with a greater range of hydrophobicity but had a lower intensity of binding than sera containing Ig CDR-H3s enriched for tyrosine or valine. We conclude that patterns of epitope recognition and binding can be heavily influenced by DH germ line sequence. This may help explain why antibodies in HIV-infected patients must undergo extensive somatic mutation in order to bind to specific viral epitopes and achieve neutralization.

Entities:  

Keywords:  Complementarity determining region (CDR-H3); Epitope; HIV-1 envelope protein; Immunoglobulin DH gene

Mesh:

Substances:

Year:  2015        PMID: 26687685      PMCID: PMC4729650          DOI: 10.1007/s00251-015-0890-x

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  42 in total

Review 1.  The RAG proteins and V(D)J recombination: complexes, ends, and transposition.

Authors:  S D Fugmann; A I Lee; P E Shockett; I J Villey; D G Schatz
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates.

Authors:  L Stamatatos; M Lim; C Cheng-Mayer
Journal:  AIDS Res Hum Retroviruses       Date:  2000-07-01       Impact factor: 2.205

3.  Characterization of molecular features, antigen-binding, and in vitro properties of IgG and IgM variants of 4E10, an anti-HIV type 1 neutralizing monoclonal antibody.

Authors:  Renate Kunert; Susanne Wolbank; Gabriela Stiegler; Robert Weik; Hermann Katinger
Journal:  AIDS Res Hum Retroviruses       Date:  2004-07       Impact factor: 2.205

4.  A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.

Authors:  J M Binley; R W Sanders; B Clas; N Schuelke; A Master; Y Guo; F Kajumo; D J Anselma; P J Maddon; W C Olson; J P Moore
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Deletion of the DQ52 element within the Ig heavy chain locus leads to a selective reduction in VDJ recombination and altered D gene usage.

Authors:  L Nitschke; J Kestler; T Tallone; S Pelkonen; J Pelkonen
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

6.  Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development.

Authors:  E Meffre; M Milili; C Blanco-Betancourt; H Antunes; M C Nussenzweig; C Schiff
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

7.  Induction of HIV-1 broad neutralizing antibodies in 2F5 knock-in mice: selection against membrane proximal external region-associated autoreactivity limits T-dependent responses.

Authors:  Laurent Verkoczy; Yao Chen; Jinsong Zhang; Hilary Bouton-Verville; Amanda Newman; Bradley Lockwood; Richard M Scearce; David C Montefiori; S Moses Dennison; Shi-Mao Xia; Kwan-Ki Hwang; Hua-Xin Liao; S Munir Alam; Barton F Haynes
Journal:  J Immunol       Date:  2013-08-05       Impact factor: 5.422

8.  Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination.

Authors:  Nicole L Yates; Hua-Xin Liao; Youyi Fong; Allan deCamp; Nathan A Vandergrift; William T Williams; S Munir Alam; Guido Ferrari; Zhi-yong Yang; Kelly E Seaton; Phillip W Berman; Michael D Alpert; David T Evans; Robert J O'Connell; Donald Francis; Faruk Sinangil; Carter Lee; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Punnee Pitisuttithum; James Tartaglia; Abraham Pinter; Susan Zolla-Pazner; Peter B Gilbert; Gary J Nabel; Nelson L Michael; Jerome H Kim; David C Montefiori; Barton F Haynes; Georgia D Tomaras
Journal:  Sci Transl Med       Date:  2014-03-19       Impact factor: 17.956

9.  Increased severity of respiratory infections associated with elevated anti-LPS IgG2 which inhibits serum bactericidal killing.

Authors:  Timothy J Wells; Deborah Whitters; Yanina R Sevastsyanovich; Jennifer N Heath; John Pravin; Margaret Goodall; Douglas F Browning; Matthew K O'Shea; Amy Cranston; Anthony De Soyza; Adam F Cunningham; Calman A MacLennan; Ian R Henderson; Robert A Stockley
Journal:  J Exp Med       Date:  2014-08-11       Impact factor: 14.307

Review 10.  Structural insights on the role of antibodies in HIV-1 vaccine and therapy.

Authors:  Anthony P West; Louise Scharf; Johannes F Scheid; Florian Klein; Pamela J Bjorkman; Michel C Nussenzweig
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582

View more
  8 in total

1.  VpreB serves as an invariant surrogate antigen for selecting immunoglobulin antigen-binding sites.

Authors:  Mohamed Khass; Tessa Blackburn; Peter D Burrows; Mark R Walter; Emidio Capriotti; Harry W Schroeder
Journal:  Sci Immunol       Date:  2016-07-14

2.  Alterations in B cell development, CDR-H3 repertoire and dsDNA-binding antibody production among C57BL/6 ΔD-iD mice congenic for the lupus susceptibility loci sle1, sle2 or sle3.

Authors:  Mohamed Khass; Robert L Schelonka; Cun Ren Liu; Ada Elgavish; Laurence Morel; Peter D Burrows; Harry W Schroeder
Journal:  Autoimmunity       Date:  2017-02       Impact factor: 2.815

3.  High-Resolution Longitudinal Study of HIV-1 Env Vaccine-Elicited B Cell Responses to the Virus Primary Receptor Binding Site Reveals Affinity Maturation and Clonal Persistence.

Authors:  Yimeng Wang; Christopher Sundling; Richard Wilson; Sijy O'Dell; Yajing Chen; Kaifan Dai; Ganesh E Phad; Jiang Zhu; Yongli Xiao; John R Mascola; Gunilla B Karlsson Hedestam; Richard T Wyatt; Yuxing Li
Journal:  J Immunol       Date:  2016-03-21       Impact factor: 5.422

4.  Absorbance summation: A novel approach for analyzing high-throughput ELISA data in the absence of a standard.

Authors:  Holly Hartman; Yuge Wang; Harry W Schroeder; Xiangqin Cui
Journal:  PLoS One       Date:  2018-06-08       Impact factor: 3.240

5.  Replacement of TCR Dβ With Immunoglobulin DH DSP2.3 Imposes a Tyrosine-Enriched TCR Repertoire and Adversely Affects T Cell Development.

Authors:  Michael Levinson; Mohamed Khass; Peter D Burrows; Harry W Schroeder
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

6.  In the Absence of Central pre-B Cell Receptor Selection, Peripheral Selection Attempts to Optimize the Antibody Repertoire by Enriching for CDR-H3 Y101.

Authors:  Mohamed Khass; Tessa Blackburn; Ada Elgavish; Peter D Burrows; Harry W Schroeder
Journal:  Front Immunol       Date:  2018-02-07       Impact factor: 7.561

Review 7.  Brief introduction of current technologies in isolation of broadly neutralizing HIV-1 antibodies.

Authors:  Zehua Sun; Lixin Yan; Jiansong Tang; Qian Qian; Jerica Lenberg; Dandan Zhu; Wan Liu; Kao Wu; Yilin Wang; Shiqiang Lu
Journal:  Virus Res       Date:  2017-10-16       Impact factor: 3.303

Review 8.  Rapid Response to Pandemic Threats: Immunogenic Epitope Detection of Pandemic Pathogens for Diagnostics and Vaccine Development Using Peptide Microarrays.

Authors:  Kirsten Heiss; Jasmin Heidepriem; Nico Fischer; Laura K Weber; Christine Dahlke; Thomas Jaenisch; Felix F Loeffler
Journal:  J Proteome Res       Date:  2020-09-21       Impact factor: 4.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.